MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.700
-0.310 (-7.73%)
Jul 24, 2026, 4:00 PM EDT - Market closed
MacroGenics Employees
MacroGenics had 293 employees as of December 31, 2025. The number of employees decreased by 48 or -14.08% compared to the previous year.
Employees
293
Change (1Y)
-48
Growth (1Y)
-14.08%
Revenue / Employee
$536,119
Profits / Employee
-$240,130
Market Cap
235.18M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | -48 | -14.08% |
| Dec 31, 2024 | 341 | 2 | 0.59% |
| Dec 31, 2023 | 339 | -18 | -5.04% |
| Dec 31, 2022 | 357 | -70 | -16.39% |
| Dec 31, 2021 | 427 | 57 | 15.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 187 |
| AC Immune | 122 |
| Orchestra BioMed Holdings | 86 |
| Cartesian Therapeutics | 75 |
| Fulcrum Therapeutics | 55 |
| Protara Therapeutics | 46 |
| Surrozen | 44 |
| Anavex Life Sciences | 34 |
MGNX News
- 3 days ago - MacroGenics provides update on MGC026 study - TheFly
- 3 days ago - MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026 - GlobeNewsWire
- 3 days ago - MacroGenics Slides: Corporate presentation - Filings
- 24 days ago - MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals - GlobeNewsWire
- 4 weeks ago - MacroGenics to receive $24.5M milestone payment from Sanofi - TheFly
- 4 weeks ago - MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval - GlobeNewsWire
- 2 months ago - MacroGenics Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 2 months ago - MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum - GlobeNewsWire